Morosini Deborah (CIK 0001824625)

Latest company ownership

Role: EVP, Chief of Clinical Affairs
Shares held
90,000
Last filed at
Feb 17, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2021 Dec 17, 2021 Prelude Therapeutics Inc EVP, Chief of Clinical Affairs Sell 7.5 -28,751 -98.48% $373.8K
Nov 16, 2021 Nov 18, 2021 Prelude Therapeutics Inc EVP, Chief of Clinical Affairs Sell 7.5 -28,751 -98.48% $456.5K
Apr 29, 2021 Apr 30, 2021 Prelude Therapeutics Inc EVP, Chief of Clinical Affairs Sell 10.0 -3,223 -87.89% $129.9K
Apr 8, 2021 Apr 15, 2021 Prelude Therapeutics Inc EVP, Chief of Clinical Affairs Sell 25.0 -100 -18.38% $4K
Apr 7, 2021 Apr 9, 2021 Prelude Therapeutics Inc EVP, Chief of Clinical Affairs Sell 13.8 -1,000 -69.25% $40K
Sep 29, 2020 Sep 29, 2020 Prelude Therapeutics Inc EVP, Chief of Clinical Affairs Buy 90.0 +444 100.00% $8.4K